Manuscripts
Showing 1573 manuscripts.
Acetyl-l-carnitine and nucleoside reverse transcriptase inhibitor-associated neuropathy in HIV infection
Citation
Justin C. McArthur, Victor G. Valcour, Tzu-min Yeh, Russell Bartt, David B. Clifford, Mariana Gerschenson, Scott Evans, Bruce A. Cohen, G. J. Ebenezer, Peter Hauer, Linda L. Millar, Mary Gould, Paul T. Tran, Cecilia M. Shikuma, Scott Souza. Acetyl-l-carnitine and nucleoside reverse transcriptase inhibitor-associated neuropathy in HIV infection. HIV Medicine. 2009. 10: 103-110.Year
          2009      
Journal
          HIV Medicine      
Hepatotoxicity and gastrointestinal intolerance when healthy volunteers taking rifampin add twice-daily atazanavir and ritonavir.
Citation
David W. Haas, Susan L. Koletar, Laura J. Laughlin, Michelle A. Kendall, Carol Suckow, John G. Gerber, Andrew R. Zolopa, Richard J. Bertz, Michael J. Child, Lara A. Hosey, Beverly L. Alston-Smith, Edward P. Acosta. Hepatotoxicity and gastrointestinal intolerance when healthy volunteers taking rifampin add twice-daily atazanavir and ritonavir.. Journal of Acquired Immune Deficiency Syndromes. 2009. 50: 290-3. PMID: 19194314Year
          2009      
Journal
          Journal of Acquired Immune Deficiency Syndromes      
Proteinuria, creatinine clearance, and immune activation in antiretroviral-naive HIV-infected subjects
Citation
Samir K. Gupta, Lauren Komarow, Roy (Trip) Gulick, Richard B. Pollard, Gregory K. Robbins, Nora Franceschini, Lynda Anne Szczech, Susan L. Koletar, Robert C Kalayjian. Proteinuria, creatinine clearance, and immune activation in antiretroviral-naive HIV-infected subjects. Journal of Infectious Diseases. 2009. 200: 614-8.Year
          2009      
Journal
          Journal of Infectious Diseases      
Production of a dendritic cell-based vaccine containing inactivated autologous virus for therapy of patients with chronic human immunodeficiency virus type 1 infection
Citation
Theresa Whiteside, P. Piazza, Nancy C. Connolly, Charles Rinaldo, Sharon A. Riddler. Production of a dendritic cell-based vaccine containing inactivated autologous virus for therapy of patients with chronic human immunodeficiency virus type 1 infection. Clinical and Vaccine Immunology. 2009. 16: 233-40.Year
          2009      
Journal
          Clinical and Vaccine Immunology      
HLA-associated immune escape pathways in HIV-1 subtype B Gag, Pol and Nef proteins
Citation
David W. Haas, Sharon A. Riddler, Zabrine J. Brumme, Richard H. Haubrich, Mina John, Bruce D. Walker, Jonathan Carlson, P. Richard Harrigan, Chanson J. Brumme, David Heckerman, Dennison Chan, Simon Mallal, Mark Brockman, Luke Swenson, Iris Tao, Sharon Szeto, Pamela Rosato, Jennifer Sela, Carl Kadie, Nicole Frahm, Christian Brander. HLA-associated immune escape pathways in HIV-1 subtype B Gag, Pol and Nef proteins. Public Library of Science One. 2009. 4: E6687.Year
          2009      
Journal
          Public Library of Science One      
A public health model for the molecular surveillance of HIV transmission in San Diego, California
Citation
Davey M. Smith, Susanne May, Samantha Tweeten, Lydia N. Drumright, Mary Pacold, Sergei L. Kosakovsky Pond, Rick L. Pesano, Yolanda Lie, Douglas D. Richman, Simon D. W. Frost, Christopher H. Woelk, Susan J. Little. A public health model for the molecular surveillance of HIV transmission in San Diego, California. AIDS. 2009. 23: 225-232.Year
          2009      
Journal
          AIDS      
A comparison of tests for restricted orderings in the three-class case
Citation
Todd A. Alonzo, Christos T. Nakas, Constantin Yiannoutsos, Sherri Bucher. A comparison of tests for restricted orderings in the three-class case. Statistics In Medicine. 2009. 28: 1144-58.Year
          2009      
Journal
          Statistics In Medicine      
Raltegravir cerebrospinal fluid concentrations in HIV-1 infection
Citation
Aylin Yilmaz, Magnus Gisslen, Serena S. Spudich, Evelyn Lee, Anura L. Jayewardene, Francesca Aweeka, Richard W. Price. Raltegravir cerebrospinal fluid concentrations in HIV-1 infection. Public Library of Science One. 2009. 4: e6877 1-5.Year
          2009      
Journal
          Public Library of Science One      
Pharmacokinetics and safety of nelfinavir when used in combination with zidovudine and lamivudine in HIV-infected pregnant womenlamivudine in HIV-infected pregnant women.
Citation
Yvonne J. Bryson, Mark Mirochnick, Alice M. Stek, Lynne M. Mofenson, James D. Connor, Edmund Capparelli, Heather D. Watts, Sharon Huang, Michael Hughes, Bethann Cunningham, Lynette Purdue, Yetemegnu Asfaw, Margaret A. Keller, Elizabeth (Betsy) Smith. Pharmacokinetics and safety of nelfinavir when used in combination with zidovudine and lamivudine in HIV-infected pregnant womenlamivudine in HIV-infected pregnant women.. HIV Clinical Trials. 2009. 9: 115-25. PMID: 18474496Year
          2009      
Journal
          HIV Clinical Trials      
Steady-state pharmacokinetics of lopinavir/ritonavir in combination with efavirenz in HIV-infected pediatric patients.
Citation
Jennifer R. King, Edward P. Acosta, Ram Yogev, Andrew A. Wiznia, Bobbie L. Graham, Vincent J. Carey, Paula Britto. Steady-state pharmacokinetics of lopinavir/ritonavir in combination with efavirenz in HIV-infected pediatric patients.. Pediatric Infectious Disease Journal. 2009. 28: 159-161. PMID: 19106779Year
          2009      
Journal
          Pediatric Infectious Disease Journal